(Q33504072)

English

A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer

scientific article

Statements

A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer (English)
1 September 1998

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit